Results 231 to 240 of about 791,464 (334)

Comprehensive analysis of cutaneous T‐cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy

Cancer, 2017
F. Ghazawi, E. Netchiporouk, E. Rahme, M. Tsang, L. Moreau, S. Glassman, N. Provost, M. Gilbert, Sara-Élizabeth Jean, K. Pehr, D. Sasseville, I. Litvinov   +11 more
semanticscholar   +1 more source

CD30 Expression in Neoplastic Mast Cells and the Presence of CD30+, CD3+, and PAX‐5+ Tumour‐Infiltrating Lymphocytes as Prognostic Markers in Canine Cutaneous Mast Cell Tumours

Veterinary and Comparative Oncology, EarlyView.
ABSTRACT Canine cutaneous mast cell tumour (MCT) is the most common skin neoplasm in dogs, with histopathology serving as both the diagnostic and primary prognostic tool. However, identifying reliable biomarkers is essential for improving clinical decision‐making.
Fernanda Ramalho Ramos, Janayna Maria Parente Serafim, Bethânia Almeida Gouveia, Pedro Luiz Porfirio Xavier, Juliano Rodrigues Sangalli, Heidge Fukumasu, Ricardo de Francisco Strefezzi   +6 more
wiley   +1 more source

Independent evolution of cutaneous lymphoma subclones in different microenvironments of the skin. [PDF]

Sci Rep, 2020
Iyer A, Hennessey D, O'Keefe S, Patterson J, Wang W, Wong GK, Gniadecki R.   +6 more
europepmc   +1 more source

Primary cutaneous anaplastic large cell lymphoma

Journal of cutaneous pathology, 2017
Ryanne A. Brown, S. Fernandez-Pol, Jinah Kim   +2 more
semanticscholar   +1 more source

Dermoscopy and the diagnosis of primary cutaneous B‐cell lymphoma

Journal of the European Academy of Dermatology and Venereology, 2018
S. Geller, A. Marghoob, A. Scope, R. Braun, P. Myskowski   +4 more
semanticscholar   +1 more source

Cutaneous T‐cell lymphoma: 2017 update on diagnosis, risk‐stratification, and management

American journal of hematology/oncology, 2017
R. Wilcox
semanticscholar   +1 more source

Treatment of Reactive Histiocytosis With Oclacitinib: A Retrospective Case Series of 10 Dogs

Veterinary Dermatology, EarlyView.
Background: Canine reactive histiocytosis is a proliferative disorder of activated interstitial dendritic cells with cutaneous and systemic forms. An immune‐mediated aetiology is likely, and systemic immunomodulatory agents such as corticosteroids, tetracycline/niacinamide, ciclosporin, azathioprine and leflunomide have been employed for its management.
Christine L. Cain, Andrew Lowe, Elizabeth A. Mauldin   +2 more
wiley   +1 more source

Prevalence, clinical features, and survival outcome trends of 627 patients with primary cutaneous lymphoma over 29 years: a retrospective review from single tertiary center in Korea. [PDF]

Sci Rep
Moon IJ, Won CH, Chang SE, Park CS, Yoon DH, Song SY, Lee MW, Lee WJ.   +7 more
europepmc   +1 more source

Cutaneous T-cell Lymphoma.

Clinics in Laboratory Medicine, 2017
M. Pulitzer
semanticscholar   +1 more source